ISU Chemical Co., Ltd

KRX:005950.KS

7800 (KRW) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 1,995,488.4532,207,647.6711,703,337.1161,313,295.2071,516,191.8571,531,336.1381,507,752.2291,515,417.5871,471,229.2041,851,575.6372,072,702.052,231,441.7932,055,883.1551,732,992.3921,505,332.0641,456,496.931939,376.523
Cost of Revenue 1,945,974.0422,057,204.711,518,326.1871,185,195.2321,419,731.4561,444,962.3331,400,019.0541,383,704.2281,391,376.0721,812,735.4261,983,171.7342,099,681.1221,906,382.0641,570,443.9541,367,162.9571,360,111.841893,717.254
Gross Profit 49,514.411150,442.961185,010.929128,099.97596,460.40286,373.805107,733.176131,713.35979,853.13238,840.21289,530.315131,760.671149,501.091162,548.438138,169.10796,385.0945,659.269
Gross Profit Ratio 0.0250.0680.1090.0980.0640.0560.0710.0870.0540.0210.0430.0590.0730.0940.0920.0660.049
Reseach & Development Expenses 18,279.70119,328.08712,663.31416,632.05516,086.90313,244.8512,813.21110,389.18,056.4267,159.6737,401.7893,848.4293,783.8026,519.3064,566.2872,952.4941,106.821
General & Administrative Expenses 4,544.8164,681.7732,752.7382,688.3573,757.9324,145.1516,639.4684,156.0664,769.5754,395.5334,961.8694,454.5985,456.0855,736.1465,205.683,997.6522,234.15
Selling & Marketing Expenses 47,433.66441,074.12448,283.16539,506.28730,260.06729,072.40125,469.64326,412.80128,821.57128,605.24127,964.42326,119.48624,197.11837,547.28934,285.18527,889.67321,270.706
SG&A 86,823.44945,755.89751,035.90342,194.64434,017.99933,217.55232,109.11130,568.86733,591.14633,000.77432,926.29230,574.08429,653.20343,283.43539,490.86531,887.32523,504.856
Other Expenses -1,955.18640,911.41433,138.255101,551.60535,492.685-986.957-6,715.641-19,650.433-6,871.692-14,887.136-5,941.091-3,121.795-8.083-14,479.23813,302.137-8,800.8-9,560.207
Operating Expenses 107,058.336105,995.39896,837.472160,378.30485,597.58778,436.03575,872.48669,042.48579,787.27274,551.95789,600.50162,161.40475,386.7185,089.23378,529.03454,838.41341,526.515
Operating Income -57,543.92550,478.188122,613.315-32,278.32917,064.9926,451.08131,125.85362,632.54853.916-35,723.882-92.41869,592.77474,205.58377,425.67259,615.64641,546.684,132.753
Operating Income Ratio -0.0290.0230.072-0.0250.0110.0040.0210.0410-0.019-00.0310.0360.0450.040.0290.004
Total Other Income Expenses Net 22,478.319-17,568.6-3,887.026-112,253.812-22,337.2741,815.648-30,402.349-44,425.994-42,624.43-54,635.243-58,576.797-39,114.714-26,301.891-34,265.784-17,165.9274,924.105-9,676.433
Income Before Tax -35,065.60532,909.588118,726.289-144,532.14-5,272.2829,753.4191,458.34118,244.88-42,558.57-90,346.989-58,646.98230,484.55347,812.4943,193.42142,474.14646,470.782-5,543.679
Income Before Tax Ratio -0.0180.0150.07-0.11-0.0030.0060.0010.012-0.029-0.049-0.0280.0140.0230.0250.0280.032-0.006
Income Tax Expense 2,696.4666,675.9522,203.863-1,389.83215,265.35911,364.2682,385.15710,381.44512,058.885-3,921.1731,806.60610,864.28228,534.5918,245.6069,067.86716,234.5863,964.073
Net Income -31,269.93127,727.24294,032.081-143,142.309-20,537.6416,810.2383,474.27610,682.741-43,388.774-58,260.534-56,212.44123,178.41819,296.88828,847.68635,514.34831,311.931-9,177.986
Net Income Ratio -0.0160.0130.055-0.109-0.0140.0040.0020.007-0.029-0.031-0.0270.010.0090.0170.0240.021-0.01
EPS -1,319.21,269.234,463.44-10,010.58-1,588.83526.99268.55825.87-3,319.62-4,428.25-4,272.061,687.71,622.533,704.633,945.093,812.5-1,128.13
EPS Diluted -1,319.21,269.234,463.44-10,010.58-1,588.83526.99268.55825.87-3,319.22-4,428.25-4,272.061,674.221,498.933,494.513,603.53,812.5-1,128.13
EBITDA -37,247.8974,763.705146,203.255-38,047.52634,553.75220,931.9637,164.8553,021.477-1,313.912-41,455.537-4,093.36567,857.20496,434.51685,722.4288,401.00256,142.86415,641.49
EBITDA Ratio -0.0190.0340.086-0.0290.0230.0140.0250.035-0.001-0.022-0.0020.030.0470.0490.0590.0390.017